The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Updated results from a phase III trial of sunitinib versus placebo in patients with progressive, unresectable, well-differentiated pancreatic neuroendocrine tumor (NET).
Aaron Vinik
Honoraria - Pfizer; Pfizer
Research Funding - Pfizer; Pfizer
Other Remuneration - Pfizer; Pfizer
Eric Van Cutsem
Research Funding - Pfizer
Patricia Niccoli
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Pfizer
Jean-Luc Raoul
No relevant relationships to disclose
Yung-Jue Bang
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Research Funding - Pfizer
Ivan Borbath
No relevant relationships to disclose
Juan W. Valle
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Peter Metrakos
No relevant relationships to disclose
Denis Smith
No relevant relationships to disclose
Jen-Shi Chen
Honoraria - Novartis; Pfizer
Dieter Hoersch
Consultant or Advisory Role - Ipsen; Novartis; Pfizer
Honoraria - Novartis; Pfizer
Research Funding - Covidien; Eckert and Ziegler ; Ipsen; MDS Nordion; Novartis
Daniel E. Castellano
No relevant relationships to disclose
Hagen F. Kennecke
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Expert Testimony - Pfizer (U)
Joel Picus
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer
Guy Van Hazel
No relevant relationships to disclose
Shem Patyna
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Dongrui (Ray) Lu
Employment or Leadership Position - Pfizer (B)
Stock Ownership - Pfizer (B)
Richard C. Chao
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Eric Raymond
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Research Funding - Pfizer